Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.48 |
| ▸ | PREP | P48147 | 4/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | S100A4 | P26447 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14348205 | 0.92 | PARP1 (0.57) | PARP1PREPACHERECQLMAPT | |
| SCHEMBL3910578 | 0.91 | PARP1 (0.44) | PARP1PREPACHERECQLMAPT | |
| SCHEMBL31281346 | 0.83 | DCTPP1 (0.48) | PARP1PREPKMT2ACA12CA1 | |
| SCHEMBL3910961 | 0.81 | PARP1 (0.38) | PARP1PREPMAPT | |
| SCHEMBL29695767 | 0.80 | ACHE (0.44) | PARP1ACHERECQLMAPTKMT2A | |
| SCHEMBL4029942 | 0.80 | LMNA (0.56) | PARP1ACHEMAPTKMT2AALDH1A1 | |
| SCHEMBL24469503 | 0.78 | PARP1 (0.49) | PARP1ACHERECQLMAPTKMT2A | |
| SCHEMBL4209630 | 0.78 | ACHE (0.43) | PARP1ACHERECQLMAPTKMT2A | |
| SCHEMBL4026308 | 0.77 | PARP1 (0.48) | PARP1ACHEKMT2AALDH1A1 | |
| SCHEMBL1612887 | 0.77 | ACHE (0.50) | ACHERECQLMAPTKMT2AMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739059-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11739059-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2023-08-29 | — | — | US | disclosed |
| US-11649339-B2 | Oxygen scavenging compositions, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11649339-B2 | Oxygen scavenging compositions, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-11345534-B2 | Oxygen scavenging compositions, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2022-05-31 | — | — | US | disclosed |
| US-11338983-B2 | Oxygen scavenging compositions, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2022-05-24 | — | — | US | disclosed |
| US-20210403423-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2021-12-30 | — | — | US | disclosed |
| US-10906870-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-10906870-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | PLASTIPAK PACKAGING, INC. (US) | 2021-02-02 | — | — | US | disclosed |
| US-20200165051-A1 | Oxygen Scavenging Compositions, Articles Containing Same, and Methods of Their Use | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2020-05-28 | — | — | US | disclosed |
| US-20110251395-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2011-10-13 | — | — | US | disclosed |
| US-20110251395-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2011-10-13 | — | — | US | disclosed |
| US-7994245-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | CONSTAR INTERNATIONAL L.L.C. (US) | 2011-08-09 | — | — | US | disclosed |
| US-7994245-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | CONSTAR INTERNATIONAL L.L.C. (US) | 2011-08-09 | — | — | US | disclosed |
| US-7994245-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | CONSTAR INTERNATIONAL L.L.C. (US) | 2011-08-09 | — | — | US | disclosed |
| WO-2008141185-A9 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | CONSTAR INTERNATIONAL, INC. (US) | 2009-09-24 | — | — | WO | disclosed |
| WO-2008141185-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | CONSTAR INTERNATIONAL, INC. (US) | 2008-11-20 | — | — | WO | disclosed |
| US-20080277622-A1 | Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2008-11-13 | — | — | US | disclosed |
| US-20080277622-A1 | Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2008-11-13 | — | — | US | disclosed |
| US-20080277622-A1 | Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use | WELLS FARGO BANK, N.A., AS ADMINISTRATIVE AGENT | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080277622-A1 | Oxygen Scavenging Molecules, Articles Containing Same, And Methods Of Their Use | SCO2, SQOR, DUOX2 | PARP1 2106/4885PREP 3528/4885ACHE 1026/4885 |
| US-20110251395-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | SCO2, SOD1, SQOR | PARP1 1956/4885PREP 3469/4885ACHE 1018/4885 |
| US-10906870-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | SQOR, SCO2, SOD1 | PARP1 2179/4885PREP 3619/4885ACHE 1196/4885 |
| US-11739059-B2 | Oxygen scavenging molecules, articles containing same, and methods of their use | SQOR, SCO2, DUOX2 | PARP1 2179/4885PREP 3594/4885ACHE 1134/4885 |
| US-20210403423-A1 | OXYGEN SCAVENGING MOLECULES, ARTICLES CONTAINING SAME, AND METHODS OF THEIR USE | SQOR, SCO2, DUOX2 | PARP1 2179/4885PREP 3594/4885ACHE 1134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.